Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | MAP3K5 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → MAP3K5 |
| (<<) CHI3L1 → MAP3K5 |
| (<<) CYP1B1 → MAP3K5 |
| (<<) EDN1 → MAP3K5 |
| (<<) EFHD2 → MAP3K5 |
| (<<) EGFR → MAP3K5 |
| (<<) GPX3 → MAP3K5 |
| (<<) GSTM3 → MAP3K5 |
| (<<) ICAM2 → MAP3K5 |
| (<<) ITGA6 → MAP3K5 |
| (<<) JAK1 → MAP3K5 |
| (<<) KCTD12 → MAP3K5 |
| (<<) MAPK6 → MAP3K5 |
| (<<) MSN → MAP3K5 |
| (<<) NCOR1 → MAP3K5 |
| (<<) NFIL3 → MAP3K5 |
| (<<) NOL9 → MAP3K5 |
| (<<) NXT1 → MAP3K5 |
| (<<) ODC1 → MAP3K5 |
| (<<) PDE2A → MAP3K5 |
| (<<) PRKCH → MAP3K5 |
| (<<) PTGER1 → MAP3K5 |
| (<<) PTGER4 → MAP3K5 |
| (<<) PTPRE → MAP3K5 |
| (<<) RPS6KA1 → MAP3K5 |
| (<<) RRAS2 → MAP3K5 |
| (<<) SEPW1 → MAP3K5 |
| (<<) SGK1 → MAP3K5 |
| (<<) SOCS5 → MAP3K5 |
| (<<) SOX18 → MAP3K5 |
| (<<) TCEAL1 → MAP3K5 |
| (<<) TMEM39B → MAP3K5 |
| (<<) UBE2J1 → MAP3K5 |
| (<<) UBE2N → MAP3K5 |
| Downstream (Children) |
|---|
| MAP3K5 → ATIC (>>) |
| MAP3K5 → ATXN1 (>>) |
| MAP3K5 → BRCA1 (>>) |
| MAP3K5 → CAMKK2 (>>) |
| MAP3K5 → CENPF (>>) |
| MAP3K5 → DUSP6 (>>) |
| MAP3K5 → EPHA4 (>>) |
| MAP3K5 → F2RL1 (>>) |
| MAP3K5 → FZD1 (>>) |
| MAP3K5 → GULP1 (>>) |
| MAP3K5 → HDAC11 (>>) |
| MAP3K5 → HSD11B1 (>>) |
| MAP3K5 → HSPA2 (>>) |
| MAP3K5 → IGFBP2 (>>) |
| MAP3K5 → MAP1B (>>) |
| MAP3K5 → PDK2 (>>) |
| MAP3K5 → PLK3 (>>) |
| MAP3K5 → PTEN (>>) |
| MAP3K5 → PTGS1 (>>) |
| MAP3K5 → RND3 (>>) |
| MAP3K5 → RPA4 (>>) |
| MAP3K5 → RPS6KA2 (>>) |
| MAP3K5 → THRA (>>) |
| MAP3K5 → WBP4 (>>) |
